Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net earnings	$ 124	$ 16,948
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	20,749	20,601
Amortization of deferred financing costs and debt discount	0	532
Amortization of premium/discount on marketable securities	1,894	(1,056)
Change in fair value of contingent consideration	(1,095)	(1,647)
Other noncash adjustments, net	2,449	2,459
Share-based compensation expense	5,897	6,306
Deferred income tax benefit	(5,482)	(435)
Changes in operating assets and liabilities:
Accounts receivable	(3,579)	21,971
Inventories	1,990	(1,851)
Prepaid expenses and other assets	(7,517)	(341)
Accrued product returns and rebates	12,952	(3,813)
Accounts payable and other liabilities	10,019	(10,548)
Net cash provided by operating activities	38,401	49,126
Cash flows from investing activities
Purchases of marketable securities	(193,700)	0
Sales and maturities of marketable securities	142,324	240,058
Purchases of property and equipment	(248)	(278)
Net cash provided by (used in) investing activities	(51,624)	239,780
Cash flows from financing activities
Proceeds from Credit Line	0	93,000
Payments on Credit Line	0	(14,637)
Proceeds from issuance of common stock	2,910	2,256
Employee taxes paid related to net share settlement of equity awards	(1,340)	(445)
Net cash provided by financing activities	1,570	80,174
Net change in cash, cash equivalents, and restricted cash	(11,653)	369,080
Cash and cash equivalents at beginning of year	75,054	93,120
Cash, cash equivalents, and restricted cash at end of period	63,401	462,200
Supplemental cash flow information
Cash paid for income taxes	336	203
Cash paid for operating leases	4,002	3,457
Noncash operating and investing activities
Lease assets obtained for new operating leases	$ 2,604	$ 2,601